Leading science, pioneering therapies

CRM Publications

Found 6 results
Filters: Keyword is Glioma  [Clear All Filters]
2014
Gangoso E, Thirant C, Chneiweiss H, Medina JM, Tabernero A.  2014.  A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.Cell Death Dis. 5:e1023.
2012
Danovi D, Folarin AA, Baranowski B, Pollard SM.  2012.  High content screening of defined chemical libraries using normal and glioma-derived neural stem cell lines.Methods Enzymol. 506:311-29.
2010
Herrero-González S, Gangoso E, Giaume C, Naus CC, Medina JM, Tabernero A.  2010.  Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells.Oncogene. 29(42):5712-23.
Danovi D, Falk A, Humphreys P, Vickers R, Tinsley J, Smith AG, Pollard SM.  2010.  Imaging-based chemical screens using normal and glioma-derived neural stem cells.Biochem Soc Trans. 38(4):1067-71.
2009
Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M et al..  2009.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.Cell Stem Cell. 4(6):568-80.
2006
Pollard SM, Conti L, Smith A.  2006.  Exploitation of adherent neural stem cells in basic and applied neurobiology.Regen Med. 1(1):111-8.